NRX Pharmaceuticals (NRXP) Shares Outstanding (2017 - 2026)

NRX Pharmaceuticals (NRXP) has 7 years of Shares Outstanding (Entity) data on file, last reported at $33.5 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 95.51% year-over-year to $33.5 million in Q1 2026; TTM through Mar 2026 was $33.5 million, a 95.51% increase from a year earlier, with the FY2025 full-year figure at $21.4 million, up 101.06% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $33.5 million, up from $21.4 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for NRXP reached as high as $33.5 million in Q1 2026 and fell as low as $6.6 million in Q4 2022.
• Historically, Shares Outstanding (Entity) has averaged $12.6 million across 5 years, with a median of $9.8 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) rose 5.5% in 2023 and soared 101.06% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $6.6 million in 2022, then grew by 26.3% to $8.4 million in 2023, then increased by 26.84% to $10.6 million in 2024, then surged by 101.06% to $21.4 million in 2025, then jumped by 56.4% to $33.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $33.5 million in Q1 2026, $21.4 million in Q4 2025, and $22.2 million in Q3 2025.